Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ART4 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | FHL3 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
mRNA | PPIP5K2 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
mRNA | CTBP2 | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-07 |
mRNA | CSF3R | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | DCANP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | IRF4 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
mRNA | ALDH8A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ABL1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MPO | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |